Naples, Fla. and Cambridge, United Kingdom, Nov. 11, 2026 Globe Newswire -- Cdt Equity Inc. Nasdaq Cdt Cdt or the Company today announced that studies have commenced with QIMA Life Sciences, a world leading preclinical d
Why Is CDT Equity Inc. (CDT) Stock Down Today?
Updated Nov 22, 2026 9:11 AM ET ยท Prev Close $0.27
Session Regime & Catalyst Assessment
68% Signal ConvictionCDT Equity Inc. Pulling Back 13.89% on 0.24x Relative Volume
CDT Equity Inc. (CDT) is pulling back 13.89% (-$0.04) to $0.23 on 0.24x average session volume. Relative to benchmarks, CDT is lagging the S&P 500 by -10.25%. 14-day RSI stands at 44.1, keeping momentum in a bearish regime.
Naples, Fla. and Cambridge, United Kingdom, Nov. 11, 2026 Globe Newswire -- Cdt Equity Inc. Nasdaq Cdt Cdt or the Company today announced that studies have commenced with QIMA Life Sciences, a world leading preclinical d
Price ($0.23) trades relative to 20-day SMA ($0.31) and 50-day SMA ($0.40).
Market & Sector Relative Strength
CDT lagging the S&P 500 by -10.25%Options Flow & Execution Desk
Recent CDT Catalyst Headlines
Verified WireNaples, Fla. and Cambridge, United Kingdom, Oct. 30, 2026 Globe Newswire -- Cdt Equity Inc. Nasdaq Cdt Cdt or the Company , today welcomed a significant development in the U.S. regulatory landscape for compounded peptide
Naples, Fla. and Cambridge, United Kingdom, Oct. 27, 2026 Globe Newswire -- Cdt Equity Inc. Nasdaq Cdt Cdt or the Company , today announced that it has entered into an evaluation agreement with Manoira Corporation Manoir
Naples, Fla. and Cambridge, United Kingdom, Oct. 14, 2026 Globe Newswire -- Cdt Equity Inc. Nasdaq Cdt Cdt or the Company today notes the announcement from Sarborg Limited regarding intellectual property covering novel s
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $0.22 (session support) for directional breakout confirmation.
Technical Regime (CDT)
BEARISH MA TRENDRetail & Crowd Sentiment
NeutralTraders on StockTwits are expressing bullish sentiment towards $CDT following after-hours price action.
About CDT Equity Inc.
CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes โฆ
Get Instant CDT Catalyst Alerts
Receive an email alert when CDT triggers an unusual volume breakout, options sweep, or rating shift.
CDT Session & Catalyst FAQ
Why is CDT stock down today?
CDT Equity Inc. (CDT) is pulling back 13.89% (-$0.04) to $0.23 on 0.24x average session volume. Relative to benchmarks, CDT is lagging the S&P 500 by -10.25%. 14-day RSI stands at 44.1, keeping momentum in a bearish regime.
Is CDT stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.24x relative volume (low participation). Our multi-factor model currently rates CDT as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the CDT Buy or Sell Decision Brief โ
What is CDT's intrinsic value and expected trading range?
At $0.23, CDT's modeled 1-to-3 session range is $0.22 โ $0.24, with a key inflection level at $0.22 (session support). Compare current price against multi-year cash flow projections in the CDT Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for CDT?
RSI at 44.1 reflects soft below-midline momentum. CDT trades at $0.23 relative to its 20-day SMA ($0.31) and 50-day SMA ($0.40), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.